Roche Resources is intended for UK Healthcare Professionals only. By entering this site you are confirming that you are a UK Healthcare professional.

Connect with our team

Click on the relevant region below to contact your local Roche representative; disease level partner (DLP) or clinical nurse educator (CNE)

Disease Level Partner & Clinical Nurse Educator
Eva McCleery

eva.mccleery@roche.com

Contact Eva
Disease Level Partner
Andy Currie

andy.currie@roche.com

Contact Andy
Disease Level Partner
Junaid Hussain

junaid.hussain@roche.com

Clinical Nurse Educator
Rachael Thirlwall

rachael.thirlwall@roche.com

Contact Junaid
Contact Rachael
Disease Level Partner
Emma Reynolds

emma.reynolds@roche.com

Clinical Nurse Educator
Rachael Thirlwall

rachael.thirlwall@roche.com

Contact Emma
Contact Rachael
Disease Level Partner
Sandy Scheiby

sandy.scheiby@roche.com

Clinical Nurse Educator
Patricia Wallace

patricia.wallace@roche.com

Contact Sandy
Contact Patricia
Disease Level Partner
Laura Brady-Locke

laura.brady-locke@roche.com

Clinical Nurse Educator
Elaine Bygrave

elaine.bygrave@roche.com

Contact Laura
Contact Elaine
Disease Level Partner
Nandika Mitchell

nandika.mitchell@roche.com

Clinical Nurse Educator
Patricia Wallace

patricia.wallace@roche.com

Contact Nandika
Contact Patricia
Disease Level Partner
Shelley Shanker

shelley.shanker@roche.com

 

Clinical Nurse Educator
Jane Ware

jane.ware@roche.com

 

Contact Shelley
Contact Jane
Disease Level Partner
Kelsey Simmonds

kelsey.simmonds.ks1@roche.com

Clinical Nurse Educator
Elaine Bygrave

elaine.bygrave@roche.com

Contact Kelsey
Contact Elaine
Disease Level Partner
Amy Foster

amy.foster@roche.com

 

Clinical Nurse Educator
Jane Ware

jane.ware@roche.com

 

Contact Amy
Contact Jane

References:

  1. OCREVUS SC Summary of Product Characteristics
  2. OCREVUS IV Summary of Product Characteristics
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. You can also report via the free Yellow Card app available from the Apple App Store or Google Play Store. Adverse events should also be reported to Roche Products Ltd. Please contact Roche Drug Safety Centre by emailing welwyn.uk_dsc@roche.com or calling +44 (0)1707 367554.

Adverse reactions should be reported by brand name and batch number.
You are about to leave the rocheresources.co.uk environment and will be redirected to another site or resource which may contain information not intended for a UK audience. Roche Products Limited does not endorse or accept liability for sites or resources controlled by third parties.